N

Netmed Inc
OTC:NTME

Watchlist Manager
Netmed Inc
OTC:NTME
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $548.5k

Netmed Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Netmed Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
N
Netmed Inc
OTC:NTME
Research & Development
-$52k
CAGR 3-Years
39%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.9B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
IDEXX Laboratories Inc
NASDAQ:IDXX
Research & Development
-$251.2m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

Netmed Inc
Glance View

Market Cap
548.5k USD
Industry
Health Care

NetMed, Inc. engages in the research and development of proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company is headquartered in Dublin Ohio, Ohio and currently employs 1 full-time employees. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The firm is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The firm is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.

NTME Intrinsic Value
Not Available
N

See Also

What is Netmed Inc's Research & Development?
Research & Development
-52k USD

Based on the financial report for Jun 30, 2002, Netmed Inc's Research & Development amounts to -52k USD.

What is Netmed Inc's Research & Development growth rate?
Research & Development CAGR 5Y
19%

Over the last year, the Research & Development growth was 59%. The average annual Research & Development growth rates for Netmed Inc have been 39% over the past three years , 19% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett